Fabio Marra
Florence, 50134, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 215 publications
GLP-1 receptor agonists at the crossroads of diabetes, hepatic steatosis, and hepatocellular carcinoma.
Journal: Internal and emergency medicine
Published: May 12, 2026
Vessels encapsulating tumor clusters predict better outcomes in advanced hepatocellular carcinoma treated with atezolizumab-bevacizumab.
Journal: JHEP reports : innovation in hepatology
Published: February 28, 2026
Sarcopenia Predicts Mortality and Hepatic Encephalopathy After TIPS in Older Adults With Cirrhosis and Improves Prognostic Scores.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: February 23, 2026
Predicting Decompensation in Unresectable Hepatocellular Carcinoma on Atezolizumab Plus Bevacizumab: The ARTE Score.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: February 13, 2026
Pre-Treatment Serum Albumin Concentration Predicts Clinical Benefit of Long-Term Albumin in Patients With Cirrhosis and Ascites.
Journal: United European gastroenterology journal
Published: February 11, 2026
Clinical impact of extrahepatic metastatic patterns in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 14, 2026
Clinical predictors of response to Atezolizumab-bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.
Journal: JHEP reports : innovation in hepatology
Published: December 29, 2025
Clinical predictors of response to atezolizumab/bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.
Journal: JHEP reports : innovation in hepatology
Published: December 29, 2025
Long-term Survival and Cure Fraction in Patients with Advanced Hepatocellular Carcinoma under Immunotherapy in Randomized Controlled Trials and Real-world Data.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 27, 2025
Altered global longitudinal strain is a common finding in liver transplant recipients with mild cardiometabolic burden.
Journal: Internal and emergency medicine
Published: December 10, 2025
Serum Procalcitonin: A Novel Tumor Biomarker for Diagnosis and Follow-Up in Fibrolamellar Hepatocellular Carcinoma.
Journal: medRxiv : the preprint server for health sciences
Published: December 03, 2025
Long-term outcomes of atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A real-world study.
Journal: Hepatology (Baltimore, Md.)
Published: November 22, 2025
Last Updated: 09/26/2026